share_log

EFFECTOR Therapeutics Q4 EPS $(3.42) Misses $(1.65) Estimate

Moomoo 24/7 ·  Mar 25 16:02

eFFECTOR Therapeutics (NASDAQ:EFTR) reported quarterly losses of $(3.42) per share which missed the analyst consensus estimate of $(1.65) by 107.27 percent. This is a 37.82 percent increase over losses of $(5.50) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment